Intelligence / Services / Auditor Changes / Benitec Biopharma Inc.
Auditchanged auditor (SEC 8-K)30 Sept 2026
Benitec Biopharma Inc.
30 Sept 2026: Changed auditor (SEC 8-K) · Ernst & Young LLP. Recorded in the SEC EDGAR full-text search.
- Filed
- 30 Sept 2026
- Ticker
- BNTC
- Sector
- Pharma and biotech
- Sic
- 2834
- Items
- 4.01
- Location
- Hayward, CA
- State
- California
- Country
- United States
- SEC CIK
- 1808898
- Reference
- 0001193125-26-409052
- Engaged
- Ernst & Young LLP
- Event
- Auditor changed
What this signal means
A new auditor brings a new audit plan: controls, accounting advisory, tax and finance-systems work are re-tendered; a resignation often signals reporting problems that need fixing fast.
- Auditor dismissed leads with 57 of 94, then Auditor resigned or declined to stand (25).
- 22 added in the 30 days to 19 Nov 2026.
Reach them with AOS
Find the decision makers at Benitec Biopharma Inc.
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this audit signal, for your approval.
Across AOS Research
Other records for Benitec Biopharma Inc. in our registers.
More in Auditor changed
Auditor Changes
16 NovRegenerex Pharma, INC.changed auditor (SEC 8-K) · Rosenfield and Company PLLCAudit6 NovAgility Robotics, Inc.changed auditor (SEC 8-K)Audit27 OctTerra Innovatum Global N.V.changed auditor (SEC 8-K) · MaloneBailey, LLPAudit22 OctNano Mobile Healthcare, Inc.changed auditor (SEC 8-K) · AOGB CPA LimitedAudit9 OctCtt Pharmaceutical Holdings, INC.changed auditor (SEC 8-K)Audit7 OctCtt Pharmaceutical Holdings, INC.changed auditor (SEC 8-K)Audit
Source: SEC EDGAR full-text search, data to 19 Nov 2026. Every Form 8-K reporting Item 4.01 (change in the registrant's certifying accountant) filed with the SEC in the last 90 days. Outgoing and incoming firms are read from the filing's wording; amendments and exhibit letters are not counted. AOS shows what the public record says; it does not verify or endorse the company.